BLISSGVS

Bliss GVS Pharma Limited

Pharmaceuticals

Share price

₹676

Market cap

₹7,125 Cr

1Y return

▲ 342%

A pharmaceutical manufacturer engaged in producing and marketing a diverse range of formulations including suppositories, pessaries, capsules, tablets, and syrups. The company operates across manufacturing, marketing, trading, and export functions, serving both domestic and international markets. Established in 1984, it has developed specialized expertise in multiple dosage forms and maintains an integrated operation across the pharmaceutical value chain to address varied healthcare requirements.

Investors holding Bliss GVS Pharma Limited

Institution

3.24%

QC

Quadrature Capital Vector Sp

Foreign Investor

1.23%

AIF

1.16%

Recent moves 7

Mates Visa Consultancy Private Limited

28 Sept 2026. Sign in to see this move

LIC sold 21,32,071 shares of Bliss GVS Pharma in the open market, decreasing its stake from 5.11% to 2.96%.

Quadrature Capital Vector SpExited

Quadrature Capital Vector Sp, which last held a 1.23 percent stake in Bliss GVS Pharma Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction in their holding to below the 1 percent disclosure threshold.

360 ONE AIFNew position

360 ONE AIF entered Bliss GVS Pharma with 12,30,285 shares, a 1.16% stake worth ₹59.48 Cr.

LIC decreased its stake in Bliss GVS Pharma from 4.33% to 3.24%, selling 1,137,703 shares worth ₹58.55 Cr at ₹514.00 apiece.

Ms. Punita SharmaDecreased

Promoter Ms. Punita Sharma sold 24,962 shares of Bliss GVS Pharma for ₹72 lakh at ₹287.40 apiece, reducing her stake from 0.02% to 0.00% and fully exiting.

Gagan Harsh SharmaDecreased

Gagan Harsh Sharma, a promoter of Bliss GVS Pharma, sold 2,17,123 shares for ₹6.24 crore at ₹287.40 apiece in an open market transaction, reducing his stake from 0.21% to 0.00% and fully exiting his position.

Track the whales in Bliss GVS Pharma Limited

Get alerted the moment a top investor buys or sells.